Table 1.
Patient and treatment characteristics.
| Variable | Statistic | All |
|---|---|---|
| Age | N | 47 |
| Mean | 53.38 | |
| Std | 14.735 | |
| Median | 54.00 | |
| IQR | (44.00; 65.00) | |
| Range | (18.00; 84.00) | |
| Gender | ||
| Female | n/N (%) | 12/47 ( 25.53%) |
| Male | n/N (%) | 35/47 ( 74.47%) |
| Histology | ||
| Others | n/N (%) | 12/47 ( 25.53%) |
| Keratinizing SCC | n/N (%) | 17/47 ( 36.17%) |
| Non keratinizing SCC | n/N (%) | 18/47 ( 38.30%) |
| EBV status | ||
| 0 | n/N (%) | 11/47 ( 23.40%) |
| 1 | n/N (%) | 36/47 ( 76.60%) |
| T classification | ||
| 1 | n/N (%) | 14/47 ( 29.79%) |
| 2 | n/N (%) | 13/47 ( 27.66%) |
| 3 | n/N (%) | 11/47 ( 23.40%) |
| 4 | n/N (%) | 9/47 ( 19.15%) |
| N classification | ||
| 0 | n/N (%) | 7/47 ( 14.89%) |
| 1 | n/N (%) | 22/47 ( 46.81%) |
| 2 | n/N (%) | 12/47 ( 25.53%) |
| 3 | n/N (%) | 6/47 ( 12.77%) |
| Stage (AJCC 8th edition) | ||
| 1 | n/N (%) | 1/47 ( 2.13%) |
| 2 | n/N (%) | 11/47 ( 23.40%) |
| 3 | n/N (%) | 21/47 ( 44.68%) |
| 4 | n/N (%) | 14/47 ( 29.79%) |
| Bulky N-disease (>15mm) | ||
| Yes | n/N (%) | 42/47 ( 89.36%) |
| No | n/N (%) | 5/47 ( 10.64%) |
| Induction chemotherapy | ||
| Yes | n/N (%) | 21/47 ( 44.68%) |
| No | n/N (%) | 26/47 ( 55.32%) |
| Concomitant chemotherapy | ||
| Yes | n/N (%) | 44/47 ( 93.62%) |
| No | n/N (%) | 3/47 ( 6.38%) |
| Initial weight (pre RT) | N | 45 |
| Mean | 80.81 | |
| Std | 14.174 | |
| Median | 80.60 | |
| IQR | (71.20; 91.10) | |
| Range | (54.30; 110.00) | |
| Initial weight (kg) | ||
| <90kg | n/N (%) | 38/47 ( 80.85%) |
| >90kg | n/N (%) | 9/47 ( 19.15%) |
| Weight loss (kg) | N | 47 |
| Mean | 6.73 | |
| Std | 3.933 | |
| Median | 6.90 | |
| IQR | (3.70; 9.20) | |
| Range | (-0.30; 16.20) | |
| % Weight loss | N | 45 |
| Mean | 8.59 | |
| Std | 4.057 | |
| Median | 8.56 | |
| IQR | (5.77; 11.24) | |
| Range | (-0.33; 15.40) | |
| Weight loss | ||
| <10% | n/N (%) | 28/47 ( 59.57%) |
| >10% | n/N (%) | 19/47 ( 40.43%) |
| BMI_PRE_RT | N | 43 |
| Mean | 26.54 | |
| Std | 4.219 | |
| Median | 26.80 | |
| IQR | (23.99; 28.77) | |
| Range | (16.86; 36.42) | |
| Response to RT (CR=1; PR=2; PD=0) | ||
| Persistent disease | n/N (%) | 2/47 ( 4.26%) |
| Complete response | n/N (%) | 42/47 ( 89.36%) |
| Partial response | n/N (%) | 3/47 ( 6.38%) |
| Status (NED=1; AWD=2; DOC=3; DOD=0) | ||
| DOD | n/N (%) | 1/47 ( 2.13%) |
| NED | n/N (%) | 41/47 ( 87.23%) |
| AWD | n/N (%) | 4/47 ( 8.51%) |
| DOC | n/N (%) | 1/47 ( 2.13%) |
SCC, squamous cell carcinoma; BMI, body mass index; RT, radiotherapy; DOD, death of disease; NED, no evidence of disease; AWD, alive with disease; DOC, death of other causes.